Biome Australia Ltd (AU:BIO) has released an update.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Biome Australia Ltd has announced that they anticipate a record-breaking first quarter in FY25, with sales revenue expected to exceed $4.0 million. This follows the previous quarter’s high of $3.8 million, signaling ongoing growth for the company that specializes in probiotics and complementary medicines aimed at improving health outcomes. Biome’s products, which are backed by clinical research, cater to various health concerns and are distributed both locally and internationally.
For further insights into AU:BIO stock, check out TipRanks’ Stock Analysis page.